Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · IEX Real-Time Price · USD
6.96
-0.24 (-3.33%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Actinium Pharmaceuticals Market Cap
Actinium Pharmaceuticals has a market cap or net worth of $207.29 million as of July 2, 2024. Its market cap has increased by 8.13% in one year.
Market Cap
207.29M
Enterprise Value
125.22M
1-Year Change
8.13%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since December 27, 2012, Actinium Pharmaceuticals's market cap has increased from $16.70M to $207.29M, an increase of 1,141.28%. That is a compound annual growth rate of 24.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 207.30M | 48.82% |
Dec 29, 2023 | 139.30M | -48.67% |
Dec 30, 2022 | 271.40M | 104.98% |
Dec 31, 2021 | 132.40M | 24.91% |
Dec 31, 2020 | 106.00M | 195.26% |
Dec 31, 2019 | 35.90M | -19.87% |
Dec 31, 2018 | 44.80M | -15.63% |
Dec 29, 2017 | 53.10M | 8.81% |
Dec 30, 2016 | 48.80M | -64.04% |
Dec 31, 2015 | 135.70M | -23.20% |
Dec 31, 2014 | 176.70M | 26.85% |
Dec 31, 2013 | 139.30M | 734.13% |
Dec 31, 2012 | 16.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Fractyl Health | 212.66M |
Skye Bioscience | 212.19M |
Profound Medical | 209.60M |
Senseonics Holdings | 208.64M |
NeuroPace | 207.99M |
Prelude Therapeutics | 204.89M |
Codexis | 203.91M |
AVITA Medical | 203.30M |